Literature DB >> 26239715

Vaccine-Drug Interactions: Cytokines, Cytochromes, and Molecular Mechanisms.

Paolo Pellegrino1, Cristiana Perrotta, Emilio Clementi, Sonia Radice.   

Abstract

Vaccinations are recommended throughout life to reduce the risk of vaccine-preventable diseases and their sequelae. Vaccines are often administered in patients with chronic diseases who are likely to be treated with several drugs. A growing number of clinical observations have indicated the possibility of interactions between vaccines and drugs, leading to changes in drug metabolism after vaccination. These interactions represent a significant concern because of the increasing use of vaccines in older patients who are likely to be treated with several drugs. Because of the possible implications of adverse reactions in terms of public health, several studies were performed to verify the risk posed by these interactions and to clarify the biologic mechanisms that drive these events. Of the several mechanisms proposed to be at the basis of vaccine-drug interactions, the most convincing evidence suggests a role of inflammatory cytokines on the regulation of specific cytochrome P450 enzymes in the liver. Differences in the cytochrome P450 enzymes involved in the metabolism of these drugs could explain these contrasting results and provide important insights to fully understand the clinical importance of these events. Further studies are required to verify whether vaccine-drug interactions may occur in other clinical settings, especially the ones for which patients are required to be vaccinated against specific diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26239715     DOI: 10.1007/s40264-015-0330-8

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  91 in total

Review 1.  Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background.

Authors:  Susanna Esposito; Elisabetta Prada; Maria Vincenza Mastrolia; Giusyda Tarantino; Claudio Codecà; Donato Rigante
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Human TH1 and TH2 subsets: doubt no more.

Authors:  S Romagnani
Journal:  Immunol Today       Date:  1991-08

Review 3.  Vaccinations for rheumatoid arthritis.

Authors:  Lisa M Perry; Kevin L Winthrop; Jeffrey R Curtis
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

4.  Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.

Authors:  Inna G Ovsyannikova; Hannah M Salk; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  Immunogenetics       Date:  2014-08-21       Impact factor: 2.846

Review 5.  Vaccine-drug interactions.

Authors:  P F D'Arcy
Journal:  Drug Intell Clin Pharm       Date:  1984-09

6.  Effects of influenza virus vaccine on hepatic drug metabolism.

Authors:  C G Meredith; C D Christian; R F Johnson; R Troxell; G L Davis; S Schenker
Journal:  Clin Pharmacol Ther       Date:  1985-04       Impact factor: 6.875

7.  Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients.

Authors:  Alessio Squassina; Marta Costa; Donatella Congiu; Mirko Manchia; Andrea Angius; Valeria Deiana; Raffaella Ardau; Caterina Chillotti; Giovanni Severino; Stefano Calza; Maria Del Zompo
Journal:  Pharmacol Res       Date:  2013-04-22       Impact factor: 7.658

8.  Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response.

Authors:  Anne P Beigneux; Arthur H Moser; Judy K Shigenaga; Carl Grunfeld; Kenneth R Feingold
Journal:  Biochem Biophys Res Commun       Date:  2002-04-26       Impact factor: 3.575

9.  Effect of influenza immunization on CYP3A4 activity in vivo.

Authors:  Mary S Hayney; Daniel Muller
Journal:  J Clin Pharmacol       Date:  2003-12       Impact factor: 3.126

Review 10.  Current strategies to minimize the bleeding risk of warfarin.

Authors:  David Snipelisky; Fred Kusumoto
Journal:  J Blood Med       Date:  2013-08-01
View more
  3 in total

1.  Examining Socioeconomic and Computational Aspects of Vaccine Pharmacovigilance.

Authors:  Vasiliki Soldatou; Anastasios Soldatos; Theodoros Soldatos
Journal:  Biomed Res Int       Date:  2019-02-19       Impact factor: 3.411

2.  Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase.

Authors:  Milo Gatti; Emanuel Raschi; Ugo Moretti; Andrea Ardizzoni; Elisabetta Poluzzi; Igor Diemberger
Journal:  Vaccines (Basel)       Date:  2021-01-04

Review 3.  Current trends in drug metabolism and pharmacokinetics.

Authors:  Yuhua Li; Qiang Meng; Mengbi Yang; Dongyang Liu; Xiangyu Hou; Lan Tang; Xin Wang; Yuanfeng Lyu; Xiaoyan Chen; Kexin Liu; Ai-Ming Yu; Zhong Zuo; Huichang Bi
Journal:  Acta Pharm Sin B       Date:  2019-10-18       Impact factor: 11.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.